mTORC1 is a well known positively regulator of malignancy, and it has been demonstrated that ROS-dependent inhibition of mTOR pathway might result in autophagy, apoptosis and cell death in ovarian cancer cells (Shi et al., 2018b; Wang et al., 2021b). Here, MTOR is linked to ovarian carcinoma.